与心力衰竭管理中的自付费用相关的挑战
Birju R Rao1, Larry A Allen2,3, Alexander T Sandhu4,5
1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA (B.R.R., N.W.D.).
Circulation. Heart failure
|February 28, 2025
概括
治疗心力衰竭的高自付费用可能会导致财务毒性. 制定具有成本效益的治疗计划需要解决患者成本,政策干预和共享决策策略.
科学领域:
- 卫生经济学 卫生经济学
- 心脏病学 心脏病学
- 卫生政策 卫生政策
背景情况:
- 对心力衰竭 (HF) 治疗的高自费费用,特别是对心力衰竭 (HF) 的指导指导医学疗法 (GDMT) 带有减少喷射率,造成了巨大的财务负担.
- 在HF患者中常见的并发症进一步增加了治疗成本和财务毒性.
- 当前的医疗保健系统在估计患者具体成本和将成本考虑纳入治疗计划方面面临挑战.
研究的目的:
- 检查心力衰竭治疗中高出口袋成本所带来的挑战.
- 探索减轻金融毒性的策略,同时优化患者的治疗结果.
- 讨论卫生政策和共同决策在管理治疗成本方面的作用.
主要方法:
- 关于心力衰竭治疗成本和财务毒性的当前文献的综述.
- 对导致心力衰竭患者自付费用的因素进行分析.
- 检查现有和拟议的卫生政策干预措施和患者层面的战略.
主要成果:
- 心力衰竭患者的自付费用是复杂的,受保险,药房福利和多种并发症的影响.
- 缓解金融毒性需要多方面的方法,包括卫生政策变化和以患者为中心的干预措施.
- 将成本讨论纳入共同决策中至关重要,但缺乏既定的最佳实践.
结论:
- 解决心力衰竭的财务毒性对于改善治疗坚持和患者福祉至关重要.
- 政策解决方案,如通货膨胀减缓法案和基于价值的保险设计,显示出减轻成本的前景.
- 加强共享决策和患者参与对于长期管理心力衰竭成本至关重要.
相关概念视频
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:22Heart Failure Drugs: Diuretics
324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:22Heart Failure Drugs: β-Blockers
306
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
306